Akèy › Kansè pankreyas › Kalifòni › Sacramento
Etid klinik pou Kansè pankreyas nan Sacramento, CA
12 etid pou Kansè pankreyas ap chèche patisipan nan sit nan ak bò kote Sacramento (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Ap rekriteFaz 1
- University of California Davis Comprehensive Cancer Center, Sacramento
Distance-Based Exercise to Preserve Function and Prevent Disability
Ap rekrite
- Kaiser Permanente-South Sacramento, Sacramento
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
Ap rekriteFaz 3
- University of California, Davis Comprehensive Cancer Center, Sacramento
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Ap rekriteFaz 1/2
- UC Davis Comprehensive Cancer Center, Sacramento
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Ap rekriteEtid obsèvasyon
- University of California Davis Comprehensive Cancer Center, Sacramento
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally Advanced Pancreatic Cancer
Ap rekriteFaz 1/2
- University of California Davis Comprehensive Cancer Center, Sacramento
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Ap rekriteFaz 3
- Sutter Medical Center Sacramento, Sacramento
Pancreatic Cancer Early Detection Consortium
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- UC Davis, Sacramento
TR-002 for the Treatment of Advanced Unresectable Metastatic Solid Tumors Unresectable or Metastatic, Refractory Pancreatic Adenocarcinoma
Ap rekriteFaz 1
- University of California Davis Comprehensive Cancer Center, Sacramento
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Ap rekriteFaz 1
- University of California, Davis Comprehensive Cancer Center, Sacramento
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
Ap rekriteFaz 3
- Mercy Cancer Center - Sacramento, Sacramento
- Sutter Medical Center Sacramento, Sacramento
- Sutter Davis Hospital, Davis · 14 mi lwen
- ak 1 plis
Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Ap rekriteFaz 1
- University of California, Davis Comprehensive Cancer Center, Sacramento
Etid Kansè pankreyas nan lòt vil
- Houston, TX61 etid
- New York City, NY60 etid
- Boston, MA43 etid
- Nashville, TN39 etid
- Los Angeles, CA35 etid
- St. Louis, MO33 etid
- Arlington, VA33 etid
- Baltimore, MD31 etid
- San Antonio, TX31 etid
- Philadelphia, PA26 etid
- Tampa, FL26 etid
- Durham, NC24 etid
Lòt etid nan Sacramento
- Kansè Poumon ki pa ti selil29 etid
- Kansè poumon22 etid
- Kansè nan tete20 etid
- Kansè pwostat19 etid
- Kansè Metastatik16 etid
- Leksemi mieloïd egi12 etid
- Ensifizyans kadyak12 etid
- Kansè (tout kalite)11 etid
- Kansè kolon11 etid
- Kansè vejik10 etid
- Kansè kolorektal10 etid
- Dyabèt Tip 29 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.